OCT 19, 2019 8:59 AM PDT

An alternative for immunotherapy-resistant cancer patients

A twist to traditional immunotherapies could help cancer patients’ immune systems better detect cancer cells, making this new system capable of targeting tumors that more conventional immunotherapies might miss. The research comes from scientists at Yale and was published recently in a study in Nature Immunology.

While immunotherapies have greatly broadened treatment options for many cancer patients by enabling their immune systems to fight cancer on their own, immunotherapy also has its own downfalls. Immunotherapy doesn’t work for all cancers or all individual cancer patients, and in fact, a common form of immunotherapy called checkpoint inhibitors are only effective in about one-third of patients. This is why continued investigation around the human immune system and its connection to cancer is crucial.

The researchers from Yale have created a new system that combines viral gene therapy and CRISPR gene-editing technology. "This is an entirely new form of immunotherapy," said senior author Sidi Chen, who is an assistant professor of genetics. The system is called Multiplexed Activation of Endogenous Genes as Immunotherapy (MAEGI).

MAEGI works like a metal-detector for cancer cells, identifying their location and later tagging them for immune destruction. By doing so, the system is able to convert cold tumors to hot tumors (cold, meaning without immune cells, and hot meaning with immune cells). Additionally, explains Chen, "Once those cells are identified, the immune system immediately recognizes them if they show up in the future.” That allows for earlier future detection.

MAEGI offers hope for patients who do not respond to immunotherapies. Photo: Pixabay

The system was proven to work in mice with melanoma, triple-negative breast and pancreatic tumors. It was capable of either reducing or completely eradicating the tumors, no matter how close or far they were from the primary tumor.

The researchers hope that MAEGI will offer an alternative treatment option for those patients who are resistant to other immunotherapies. The team will be continuing their research to prepare for human clinical trials.

Sources: Yale, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
FEB 14, 2021
Cancer
Your daily commute exposes you to these two carcinogens
FEB 14, 2021
Your daily commute exposes you to these two carcinogens
New research from UC Riverside reports alarming findings on the risks of exposure to carcinogenic chemicals from time sp ...
MAR 15, 2021
Cell & Molecular Biology
Newly-ID'ed Organelle May Play a Role in Cancer Metastasis
MAR 15, 2021
Newly-ID'ed Organelle May Play a Role in Cancer Metastasis
Cells are packed full of organelles and molecules like proteins floating in a liquid known as cytoplasm. In recent years ...
MAR 12, 2021
Cancer
Toxic molecules in flame retardants increase breast cancer risk
MAR 12, 2021
Toxic molecules in flame retardants increase breast cancer risk
New research reported in the February issue of the journal Toxicological Sciences suggests that brominated flame re ...
MAR 31, 2021
Cancer
Understanding the risk of thrombosis for cancer patients
MAR 31, 2021
Understanding the risk of thrombosis for cancer patients
New research from the Comprehensive Cancer Center (CCC) of Medical University of Vienna and Vienna General Hospital sugg ...
APR 04, 2021
Drug Discovery & Development
Ion-Pump for Chemotherapy
APR 04, 2021
Ion-Pump for Chemotherapy
Patients of malignant brain tumors experience recurrences even after subsequent treatments. To address this issue, scien ...
APR 19, 2021
Health & Medicine
Using Artificial Intelligence to Understand the Language of Cancer and Alzheimer's Disease
APR 19, 2021
Using Artificial Intelligence to Understand the Language of Cancer and Alzheimer's Disease
Cancer and Alzheimer’s disease are life-changing, and there is still much we don’t understand about what cau ...
Loading Comments...